[{"address1": "3580 CARMEL MOUNTAIN ROAD", "address2": "SUITE 200", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1040", "fax": "858 614 7007", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is headquartered in San Diego, California.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barry D. Quart Pharm.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 547466, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David L. Szekeres J.D.", "age": 50, "title": "President", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 409305, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Peraza CPA", "age": 47, "title": "Vice President of Finance", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 210889, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Cohn J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean T. Ristine", "age": 54, "title": "Vice President of Human Resources", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 60, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul  Collazo Ph.D.", "age": 57, "title": "VP & Global Head of Medical Affairs", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srikanth  Pendyala M.D.", "title": "Senior Vice President of Clinical Development(Consultant)", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly J. Manhard", "age": 64, "title": "Executive VP & Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.727, "open": 0.769, "dayLow": 0.73, "dayHigh": 0.7912, "regularMarketPreviousClose": 0.727, "regularMarketOpen": 0.769, "regularMarketDayLow": 0.73, "regularMarketDayHigh": 0.7912, "payoutRatio": 0.0, "beta": -0.293, "forwardPE": -3.7549999, "volume": 73764, "regularMarketVolume": 73764, "averageVolume": 115108, "averageVolume10days": 81510, "averageDailyVolume10Day": 81510, "bid": 0.0, "ask": 0.7996, "bidSize": 0, "askSize": 1, "marketCap": 41567248, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 2.07, "priceToSalesTrailing12Months": 1.5967137, "fiftyDayAverage": 0.75258, "twoHundredDayAverage": 1.024185, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -53291124, "profitMargins": -0.60030997, "floatShares": 14161648, "sharesOutstanding": 55349200, "sharesShort": 48519, "sharesShortPriorMonth": 5404, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.40807998, "heldPercentInstitutions": 0.44629002, "shortRatio": 0.19, "shortPercentOfFloat": 0.0014, "impliedSharesOutstanding": 58623000, "bookValue": 1.665, "priceToBook": 0.45105106, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15628000, "trailingEps": -0.28, "forwardEps": -0.2, "enterpriseToRevenue": -2.047, "enterpriseToEbitda": 2.445, "52WeekChange": -0.5646707, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 0.751, "targetHighPrice": 8.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 93708000, "totalCashPerShare": 1.693, "ebitda": -21792000, "totalDebt": 178000, "quickRatio": 11.198, "currentRatio": 11.458, "totalRevenue": 26033000, "debtToEquity": 0.193, "revenuePerShare": 0.472, "returnOnAssets": -0.12274, "returnOnEquity": -0.16139, "grossProfits": 26033000, "freeCashflow": -23097500, "operatingCashflow": -23612000, "grossMargins": 1.0, "ebitdaMargins": -0.83709, "operatingMargins": -14.81168, "financialCurrency": "USD", "symbol": "CNTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 3.3012364, "regularMarketPrice": 0.751, "corporateActions": [], "postMarketTime": 1747430843, "regularMarketTime": 1747425600, "exchange": "NGM", "messageBoardId": "finmb_706016439", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "shortName": "Connect Biopharma Holdings Limi", "postMarketChangePercent": 7.58989, "postMarketPrice": 0.808, "postMarketChange": 0.057, "regularMarketChange": 0.023999989, "regularMarketDayRange": "0.73 - 0.7912", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 115108, "fiftyTwoWeekLowChange": 0.241, "fiftyTwoWeekLowChangePercent": 0.47254902, "fiftyTwoWeekRange": "0.51 - 2.07", "fiftyTwoWeekHighChange": -1.319, "fiftyTwoWeekHighChangePercent": -0.6371981, "fiftyTwoWeekChangePercent": -56.467068, "longName": "Connect Biopharma Holdings Limited", "earningsTimestamp": 1747314002, "earningsTimestampStart": 1747314002, "earningsTimestampEnd": 1747314002, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.2, "epsCurrentYear": -0.975, "priceEpsCurrentYear": -0.7702564, "fiftyDayAverageChange": -0.0015799999, "fiftyDayAverageChangePercent": -0.0020994446, "twoHundredDayAverageChange": -0.27318496, "twoHundredDayAverageChangePercent": -0.266734, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "cryptoTradeable": false, "displayName": "Connect Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]